SCHEMBL4923069

SCHEMBL4923069

CC1(C)CC(=O)c2c(S(C)(=O)=O)sc(C(=O)OCc3cccc(OC(F)(F)F)c3)c2C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
PKM P14618 2/20 0.48
CACNA1G O43497 1/20 0.39
CACNA1H O95180 1/20 0.39
CACNA1I Q9P0X4 1/20 0.39
LRRK2 Q5S007 1/20 0.38
KCNN4 O15554 1/20 0.36
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
MMP14 P50281 1/20 0.36
ADAM17 P78536 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
BUB1 O43683 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
AMPD2 Q01433 1/20 0.35
MMP1 P03956 1/20 0.35
MMP12 P39900 1/20 0.35
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927718 0.89 ALDH1A1 (0.47) ALDH1A1PKMLRRK2KCNN4MMP1
SCHEMBL4929155 0.86 ALDH1A1 (0.52) ALDH1A1PKMLRRK2MMP2MMP9
SCHEMBL4937751 0.86 ALDH1A1 (0.49) ALDH1A1PKMLRRK2MMP2MMP9
SCHEMBL4925499 0.83 ALDH1A1 (0.47) ALDH1A1PKMLRRK2MAPTLMNA
SCHEMBL4929382 0.81 ALDH1A1 (0.50) ALDH1A1PKMLRRK2MAPTLMNA
SCHEMBL4923939 0.80 ALDH1A1 (0.46) ALDH1A1PKMCACNA1GCACNA1HCACNA1I
SCHEMBL4929847 0.80 ALDH1A1 (0.48) ALDH1A1PKMCACNA1GCACNA1HCACNA1I
SCHEMBL4930488 0.79 ALDH1A1 (0.48) ALDH1A1PKMLRRK2MAPTLMNA
SCHEMBL4924612 0.78 ALDH1A1 (0.51) ALDH1A1PKMLRRK2MAPTLMNA
SCHEMBL4918258 0.78 ALDH1A1 (0.47) ALDH1A1PKMLRRK2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR ALDH1A1 2002/4885PKM 2177/4885CACNA1G 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.